HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenjiro Kohri Selected Research

Prostatic Hyperplasia (Benign Prostatic Hyperplasia)

5/2014Interleukin-18 may lead to benign prostatic hyperplasia via thrombospondin-1 production in prostatic smooth muscle cells.
1/2013Impact of four loci on serum tamsulosin hydrochloride concentration.
10/2012Regulation of cell proliferation through a KIT-mediated mechanism in benign prostatic hyperplasia.
1/2012Tamsulosin reduces nighttime urine production in benign prostatic hyperplasia patients with nocturnal polyuria: a prospective open-label long-term study using frequency-volume chart.
10/2011Up-regulation of α1a and α1d-adrenoceptors in the prostate by administration of subtype selective α1-adrenoceptor antagonist tamsulosin in patients with benign prostatic hyperplasia.
2/2011Correlation between expression of α₁-adrenoceptor subtype mRNA and severity of lower urinary tract symptoms or bladder outlet obstruction in benign prostatic hyperplasia patients.
10/2009Prostate growth inhibition by subtype-selective alpha(1)-adrenoceptor antagonist naftopidil in benign prostatic hyperplasia.
3/2008Expression of alpha1-adrenoceptor subtype mRNA as a predictor of the efficacy of subtype selective alpha1-adrenoceptor antagonists in the management of benign prostatic hyperplasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenjiro Kohri Research Topics

Disease

27Neoplasms (Cancer)
01/2016 - 01/2002
24Prostatic Neoplasms (Prostate Cancer)
02/2015 - 03/2002
17Kidney Calculi (Kidney Stone)
04/2024 - 04/2007
15Cryptorchidism (Undescended Testes)
08/2018 - 12/2005
13Hypospadias
01/2015 - 02/2002
12Urolithiasis
01/2022 - 06/2004
11Neoplasm Metastasis (Metastasis)
09/2015 - 01/2003
10Urinary Bladder Neoplasms (Bladder Cancer)
02/2016 - 01/2000
10Carcinoma (Carcinomatosis)
09/2015 - 03/2004
8Inflammation (Inflammations)
05/2019 - 12/2010
8Calculi (Calculus)
04/2018 - 02/2007
8Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
05/2014 - 03/2008
7Urinary Calculi (Urinary Calculus)
05/2019 - 02/2002
6Shock
04/2018 - 11/2006
5Bone Resorption
01/2022 - 06/2004
5Overactive Urinary Bladder (Overactive Bladder)
01/2018 - 09/2004
5Gout
06/2011 - 06/2011
5Hyperuricemia
06/2011 - 06/2011
4Hemorrhage
11/2017 - 02/2014
4Vesico-Ureteral Reflux (Vesicoureteral Reflux)
10/2014 - 01/2010
4Hyperthermia
01/2014 - 09/2005
4Renal Cell Carcinoma (Grawitz Tumor)
09/2008 - 04/2005
3Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2015 - 01/2011
3Margins of Excision
10/2014 - 01/2011
3Adenocarcinoma
07/2014 - 12/2007
3Nephrolithiasis
09/2013 - 01/2005
3Urinary Tract Infections (Urinary Tract Infection)
08/2013 - 01/2010
3Carcinogenesis
04/2012 - 03/2004
3Urinary Retention
10/2011 - 01/2009
3Hyperplasia
10/2009 - 09/2007
2Infections
01/2019 - 11/2008
2Postoperative Pain
04/2018 - 01/2007
2Kidney Neoplasms (Kidney Cancer)
03/2018 - 03/2011
2Hyperlipidemias (Hyperlipidemia)
12/2015 - 01/2008
2Renal Insufficiency (Renal Failure)
02/2014 - 04/2010

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
01/2020 - 03/2002
12CalciumIBA
01/2022 - 02/2002
10Calcium OxalateIBA
04/2024 - 01/2005
9Hormones (Hormone)IBA
02/2015 - 03/2002
8Uric Acid (Urate)IBA
01/2022 - 11/2008
8AndrogensIBA
09/2014 - 09/2005
6Diphosphonates (Bisphosphonates)IBA
01/2022 - 06/2004
6OsteopontinIBA
01/2017 - 06/2004
6Cisplatin (Platino)FDA LinkGeneric
12/2014 - 03/2002
6Prostate-Specific Antigen (Semenogelase)IBA
01/2014 - 01/2003
5Transcription Factors (Transcription Factor)IBA
01/2020 - 06/2006
5Ethylene Glycol (Monoethylene Glycol)IBA
01/2016 - 04/2007
5MineralsIBA
12/2015 - 11/2004
5Liposomes (Liposome)IBA
06/2013 - 01/2002
5Xanthine OxidaseIBA
06/2011 - 06/2011
5FebuxostatFDA Link
06/2011 - 06/2011
5Messenger RNA (mRNA)IBA
02/2011 - 06/2006
4calcium phosphateIBA
01/2022 - 06/2004
4OxalatesIBA
01/2022 - 01/2010
4Complementary DNA (cDNA)IBA
05/2014 - 05/2002
4RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
04/2014 - 08/2010
4Ferrosoferric Oxide (Magnetite)FDA Link
01/2014 - 01/2002
4Allopurinol (Remid)FDA LinkGeneric
06/2011 - 06/2011
4purineIBA
06/2011 - 06/2011
3Alendronate (Alendronate Sodium)FDA LinkGeneric
01/2022 - 06/2004
3glyoxylic acid (glyoxylate)IBA
01/2020 - 04/2007
3Biomarkers (Surrogate Marker)IBA
01/2016 - 01/2003
3DNA (Deoxyribonucleic Acid)IBA
12/2014 - 01/2008
3Androgen Receptors (Androgen Receptor)IBA
11/2014 - 03/2002
3Matrix Gla ProteinIBA
01/2013 - 06/2007
3Tamsulosin (Flomax)FDA LinkGeneric
01/2013 - 10/2011
3Flutamide (Eulexin)FDA LinkGeneric
06/2010 - 03/2002
3LigandsIBA
01/2008 - 06/2003
3AntigensIBA
12/2007 - 06/2003
2Collagen Type I (Type I Collagen)IBA
01/2022 - 01/2003
2Acetylcysteine (Siran)FDA LinkGeneric
01/2020 - 03/2002
2LipidsIBA
01/2019 - 12/2015
2AntioxidantsIBA
01/2019 - 01/2005
2ButylhydroxybutylnitrosamineIBA
01/2016 - 03/2008
2Pioglitazone (Actos)FDA Link
01/2016 - 09/2012
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2016 - 09/2012
2Etoposide (VP 16)FDA LinkGeneric
12/2014 - 03/2002
2cyanuric acidIBA
02/2014 - 04/2010
2melamineIBA
02/2014 - 04/2010
2GemcitabineFDA Link
01/2014 - 12/2007

Therapy/Procedure

26Therapeutics
02/2016 - 03/2002
10Nephrectomy
03/2018 - 07/2007
10Drug Therapy (Chemotherapy)
09/2015 - 04/2005
9Prostatectomy (Retropubic Prostatectomy)
10/2014 - 01/2006
8Lithotripsy (Extracorporeal Shockwave Lithotripsy)
04/2024 - 11/2006
7Orchiopexy
06/2011 - 12/2005
5Radiotherapy
04/2015 - 03/2008
5Intravesical Administration
10/2012 - 01/2000
4Castration
02/2015 - 01/2009
4Orchiectomy (Orchidectomy)
12/2014 - 01/2007
3Transurethral Resection of Bladder
09/2015 - 01/2010
3Replantation
10/2014 - 05/2012
3Operative Time
10/2014 - 08/2012
3Cystectomy
01/2014 - 01/2010
3Bed Rest (Bedrest)
12/2012 - 11/2004
3Operative Surgical Procedures
07/2008 - 02/2002
2Punctures
11/2017 - 01/2009
2Immunotherapy
09/2015 - 03/2011
2Percutaneous Nephrolithotomy
01/2015 - 01/2014
2Sutures (Suture)
01/2014 - 08/2013